Pictet Asset Management Holding SA

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1993888 CAROUGE, V8

Position in BBIO

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$107,856,424

+$5,289,701 QoQ

Shares Held

1,448,126

+4.8% QoQ

Ownership

0.741%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#34

of 472 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

Pictet Asset Management Holding SA holds $3,960,623,527 across 131 Biotechnology names. BBIO ranks #7 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	539,255	$267,864,136
2	RVMD	Revolution Medicines, Inc.	1,014,894	$190,069,348
3	ARGX	Argenx SE	198,282	$183,960,091
4	INSM	INSMED Inc	1,220,353	$130,114,036
5	IONS	Ionis Pharmaceuticals Inc	1,596,998	$126,625,971
6	ROIV	Roivant Sciences Ltd.	3,468,340	$122,744,552
7	BBIO	BridgeBio Pharma, Inc. This page	1,448,126	$107,856,424
8	RYTM	Rhythm Pharmaceuticals, Inc.	957,785	$106,342,868

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$107,856,424	1,448,126	+4.8%	Shares	Sole	2026-07-30
2026-03-31	$102,566,723	1,381,184	+8.7%	Shares	Sole	2026-04-22
2025-12-31	$97,164,482	1,270,290	+12.1%	Shares	Sole	2026-01-29
2025-09-30	$58,866,250	1,133,351	-37.3%	Shares	Sole	2025-11-18
2025-06-30	$78,045,000	1,807,434	-13.5%	Shares	Sole	2025-08-13
2025-03-31	$72,260,564	2,090,268	+15.6%	Shares	Sole	2025-05-05
2024-12-31	$49,597,031	1,807,472	-35.5%	Shares	Sole	2025-02-12
2024-09-30	$71,365,831	2,803,057	+5.8%	Shares	Sole	2024-11-12
2024-06-30	$67,098,080	2,648,957	-9.7%	Shares	Sole	2024-08-13
2024-03-31	$90,670,704	2,932,429	+6.0%	Shares	Sole	2024-05-14
2023-12-31	$111,711,258	2,767,185	+1.0%	Shares	Sole	2024-02-13
2023-09-30	$72,254,380	2,740,022	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.